Found: 2
Select item for more details and to access through your institution.
Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0161484
- By:
- Publication type:
- Article
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 127, n. 3, p. 569, doi. 10.1007/s11060-016-2065-5
- By:
- Publication type:
- Article